Vifor Fresenius Medical Care Renal Pharma
Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.
-
New drug trial aims to keep kidney patients' potassium in check
Disease control CompletedThis study tested a medication called patiromer in Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely and effectively lower potassium, allowing patients to continue taking their important heart and kidney medication…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Breakthrough trial targets debilitating itch for dialysis patients
Symptom relief CompletedThis study tested whether a medication called difelikefalin could reduce severe itching in Chinese adults receiving hemodialysis for kidney failure. For 12 weeks, 260 participants received either the drug or a placebo injection three times a week after their dialysis sessions. Th…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC